Retiro De Equipo (Recall) de Dimension® QuickLYTE Integrated Multisensor

Según L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en France que fue producido por Dade-Behring.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
  • Fecha
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Notas adicionales en la data
  • Acción
    On 28 June 2005, the company Dade-Behring withdrew lots 5BD812 (28.08.2005), 5DD820 (18.10.2005), 5CD813 (07.09.2005) and 5DD821 (25.10.2005). ), 5CD816 (dated 28.09.2005), 5DD828 (dated 11.10.2005), 5DD817 (dated 04.10.2005) of the in vitro diagnostic medical device called Dimension® QuickLYTE Integrated Multisensor reference S600 .. This decision follows the possibility of obtaining results of urinary chlorine (patient and quality control) having a positive bias of 10 to 50%. This device is used for the quantitative measurement of sodium, potassium, chlorine and total carbon dioxide in serum and heparinized plasma and to the quantitative measurement of sodium, potassium and chlorine in the urine. The company has directly notified the recipients of the offending lots by means of the attached message (28/06 / 2005) (12 KB) validated by Afssaps .. The relevant European Competent Authorities are informed directly by the manufacturer. This information is intended for laboratory managers, directors of health establishments and reactive vigilance correspondents for dissemination, where appropriate, to the services concerned.


  • Modelo / Serial
  • Descripción del producto
  • Manufacturer


  • Source